Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate ARTHRITIS & RHEUMATOLOGY Kivitz, A. J., Gutierrez-Urena, S. R., Poiley, J., Genovese, M. C., Kristy, R., Shay, K., Wang, X., Garg, J. P., Zubrzycka-Sienkiewicz, A. 2017; 69 (4): 709-719

View details for DOI 10.1002/art.39955

View details for Web of Science ID 000397615900003